| Structure | Chemical Name | CAS | MF |
|
3-(2-Hydroxyethoxycarbonyl)-5-(sodiosulfo)benzoic acid
|
57911-49-6
|
|
|
2,4-Cyclohexadien-1-one, 6-(oxoethenylidene)- (9CI)
|
57912-01-3
|
C8H4O2
|
|
Ethenone, (6-methylene-2,4-cyclohexadien-1-ylidene)- (9CI)
|
57912-04-6
|
C9H6O
|
|
Z-CYS(Z)-OH
|
57912-35-3
|
C19H19NO6S
|
|
2-Propenoic acid, 2-methyl-, polymer with 2-hydroxypropyl 2-methyl-2-propenoate and methyl 2-methyl-2-propenoate
|
57912-75-1
|
C16H26O7
|
|
bis(p-isopropylphenyl) sulphone
|
57913-35-6
|
C18H22O2S
|
|
XYLAMINE HYDROCHLORIDE
|
57913-68-5
|
C12H19Cl2N
|
|
2-Propenenitrile, polymer with ethenylbenzene and methyloxirane polymer with oxirane ether with 1,2,3-propanetriol (3:1)
|
57913-80-1
|
C19H29NO5
|
|
4-bromo-5-methyl-2-Thiopheneacetic acid
|
57915-33-0
|
C7H7BrO2S
|
|
2,3-DICHLOROBENZYL BROMIDE
|
57915-78-3
|
C7H5BrCl2
|
|
3-(2,3-DICHLOROPHENYL)PROPIONIC ACID
|
57915-79-4
|
C9H8Cl2O2
|
|
3-(2,3-DICHLORO-PHENYL)-PROPAN-1-OL
|
57915-80-7
|
C9H10Cl2O
|
|
3-CHLORO-6-BROMO INDOLE
|
57916-08-2
|
C8H5BrClN
|
|
L-SALSOLINOL HYDROCHLORIDE)
|
57916-10-6
|
C10H14ClNO2
|
|
1-(N-Salicyloyl)amino-3-salicyloylguanidine
|
57916-13-9
|
C15H14N4O4
|
|
Iclazepam
|
57916-70-8
|
C21H21ClN2O2
|
|
Poly[oxy(methyl-1,2-ethanediyl)], .alpha.,.alpha.',.alpha.''-1,2,3-propanetriyltris[.omega.-hydroxy-, (Z)-2-butenedioate
|
57916-86-6
|
C4H4O4.x(C3H6O)n(C3H6O)n(C3H6O)nC3H8O3
|
|
|
Cavitec
|
57916-94-6
|
|
|
|
hementerin
|
57917-09-6
|
|
|
|
Hypocal
|
57917-14-3
|
|
|
|
BEET RED
|
57917-55-2
|
C18H25NO
|
|
1-Isopropyl Etodolac
|
57917-63-2
|
C18H23NO3
|
|
erythralosamine-2',3-diacetate
|
57917-99-4
|
C33H53NO10
|
|
Vitamin D3 β-D-Glucuronide
|
57918-08-8
|
C33H52O7
|
|
3-ACETOXY-2-CYCLOHEXEN-1-ONE
|
57918-73-7
|
C8H10O3
|
|
2-methyl-3-(o-tolyl)propionaldehyde
|
57918-84-0
|
C11H14O
|
|
Dexphenmetrazine
|
57919-12-7
|
C11H15NO
|
|
ALUMINUM OXIDE-CHROMIUM OXIDE
|
57921-51-4
|
Al2CrO6
|
|
Naprodoximine
|
57925-64-1
|
C13H14N2O2
|
|
4-Methyl-3,5-dinitropyridine
|
57927-98-7
|
C6H5N3O4
|
|
4-BENZYLOXY-BENZAMIDINE
|
57928-60-6
|
C14H14N2O
|
|
3-(Phenoxymethyl)benzonitrile
|
57928-72-0
|
C14H11NO
|
|
3-(2-hydroxyethoxy)benzonitrile
|
57928-93-5
|
C9H9NO2
|
|
4-(2-hydroxyethoxy)benzonitrile
|
57928-96-8
|
C9H9NO2
|
|
HydrazinecarboxaMide, N-(1-Methylethyl)-
|
57930-20-8
|
C4H11N3O
|
|
(3aR,4S,5R,6aS)-4-[(Acetyloxy)methyl]hexahydro-5-hydroxy-2H-cyclopenta[b]furan-2-one
|
57930-46-8
|
C10H14O5
|
|
20-HYDROXY PROSTAGLANDIN F2ALPHA
|
57930-92-4
|
C20H34O6
|
|
20-HYDROXY PROSTAGLANDIN E2
|
57930-95-7
|
C20H32O6
|
|
20-hydroxyprostaglandin E1
|
57930-99-1
|
C20H34O6
|
|
16,16-dimethyl-delta(4)-prostaglandin F1alpha
|
57931-23-4
|
C22H38O5
|
|
(hexyloxy)acetic acid
|
57931-25-6
|
C8H16O3
|
|
3-Quinolinecarboxylic acid, 1,2-dihydro-4-hydroxy-1-Methyl-2-oxo-
|
57931-81-4
|
C11H9NO4
|
|
Formamide, N-(3-oxobutyl)- (6CI,9CI)
|
57932-02-2
|
C5H9NO2
|
|
4'-Ethoxy-2-(1H-indol-3-yl)acetanilide
|
57932-46-4
|
C18H18N2O2
|
|
(2S)-2β-(Formyloxy)-1,2,3,4,4a,10aα-hexahydro-5,6,8-trihydroxy-7-[(R)-1-methyl-2-hydroxyethyl]-1,1,4aβ-trimethyl-9,10-phenanthrenedione
|
57932-72-6
|
C21H26O8
|
|
6β,7α,12-Trihydroxyabieta-8,12-diene-11,14-dione
|
57932-73-7
|
C20H28O5
|
|
(5α,12R,19α)-2,3-Didehydro-6α-hydroxy-3-(methoxycarbonyl)aspidospermidin-21-oic acid γ-lactone
|
57932-86-2
|
C21H22N2O4
|
|
8-METHYL-2,3,4,5-TETRAHYDRO-1H-PYRIDO[4,3-B]INDOLE HYDROCHLORIDE
|
57933-28-5
|
C12H15ClN2
|
|
Isopropenyl chloroformate
|
57933-83-2
|
C4H5ClO2
|
|
Bis(dimethylamino)phosphorylchloride,93+%
|
57934-39-1
|
C4H12ClN2OP
|
|
GIVESCONE
|
57934-97-1
|
C13H22O2
|
|
(E)-1-(2-ethyl-6,6-dimethyl-1-cyclohexen-1-yl)-2-buten-1-one
|
57934-98-2
|
C14H22O
|
|
(E)-1-(2-ethyl-6,6-dimethyl-2-cyclohexen-1-yl)-2-buten-1-one
|
57934-99-3
|
C14H22O
|
|
(E,Z)-1-(6-ethylidene-2,2-dimethylcyclohexyl)-2-buten-1-one
|
57935-00-9
|
C14H22O
|
|
(E,E)-1-(6-ethylidene-2,2-dimethylcyclohexyl)-2-buten-1-one
|
57935-01-0
|
C14H22O
|
|
2,4-Cyclohexadiene-1-carbonyl chloride, 2-ethyl-6,6-dimethyl- (9CI)
|
57935-25-8
|
C11H15ClO
|
|
1,3-Cyclohexadiene-1-carbonyl chloride, 2-ethyl-6,6-dimethyl- (9CI)
|
57935-26-9
|
C11H15ClO
|
|
3-Cyclohexene-1-carbonyl chloride, 2-ethylidene-6,6-dimethyl- (9CI)
|
57935-27-0
|
C11H15ClO
|
|
4-HYDROXY-6,8-DICHLOROQUINOLINE
|
57935-38-3
|
C9H5Cl2NO
|
|
Tiomergine
|
57935-49-6
|
C21H21N3S
|
|
2-CHLOROMETHYLIMIDAZO[1,2-A]PYRAZINE
|
57937-60-7
|
C7H6ClN3
|
|
ethyl N-[(2-hydroxyphenyl)methyl]glycinate
|
57938-78-0
|
C11H15NO3
|
|
2-[[(2-hydroxyphenyl)methyl]amino]acetamide
|
57938-79-1
|
C9H12N2O2
|
|
adinazolam mesylate
|
57938-82-6
|
C20H22ClN5O3S
|
|
Potassium (R)-((3-ethoxy-1-methyl-3-oxoprop-1-enyl)amino)(4-hydroxyphenyl)acetate
|
57938-86-0
|
C14H16KNO5
|
|
1-(1H-Pyrazol-1-yl)propan-2-aMine
|
57939-04-5
|
C14H12N2O7S
|
|
6-amino-2-(prop-2-en-1-ylsulfanyl)pyrimidin-4(3H)-one
|
57939-40-9
|
C7H9N3OS
|
|
4,6,7-TRICHLOROQUINAZOLINE
|
57940-05-3
|
C8H3Cl3N2
|
|
ethyl (cyclohexyloxy)acetate
|
57941-70-5
|
C10H18O3
|
|
Aminazolin diphosphate
|
57942-49-1
|
C25H36Cl2N4O8P2
|
|
Acetamide, N-[3-[(hydroxyamino)iminomethyl]-2-thienyl]- (9CI)
|
57942-56-0
|
C7H9N3O2S
|
|
AKOS B017837
|
57942-77-5
|
C14H24N2
|
|
(17S,20S)-5α-Pregnane-3β,12β,14β,17,20-pentol 12,20-diacetate
|
57943-41-6
|
C25H40O7
|
|
METHYL 4-HYDROXYBENZIMIDATE HYDRO-CHLORIDE
|
57943-60-9
|
C8H10ClNO2
|
|
phenethyl nonanoate
|
57943-67-6
|
C17H26O2
|
|
N,N-diethyl-4-[[2,5-dimethoxy-4-[(4-nitrophenyl)azo]phenyl]azo]aniline
|
57943-75-6
|
C24H26N6O4
|
|
sodium [2R-(2alpha,3Z,5alpha)]-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate
|
57943-81-4
|
C8H8NNaO5
|
|
Methyl
|
57943-82-5
|
C9H11NO5
|
|
Guanosine 5'-phosphoric acid-3'-diphosphoric acid pentalithium salt
|
57944-01-1
|
C10H17LiN5O14P3
|
|
2,5-Anhydro-D-allonothioaMide 3,4,6-Tribenzoate
|
57944-10-2
|
C27H23NO7S
|
|
3′-Deoxy-3′-fluorouridine
|
57944-13-5
|
C9H11FN2O5
|
|
Officinalisinin I
|
57944-18-0
|
C45H76O19
|
|
1A,1B-DIHOMO PROSTAGLANDIN F2ALPHA
|
57944-39-5
|
C22H38O5
|
|
hydroxyaldol-histidine
|
57944-40-8
|
C18H29N5O7
|
|
2-Naphthalenol,7-ethoxy-(9CI)
|
57944-44-2
|
C12H12O2
|
|
2,3-DIHYDRO-1H-ISOINDOLE-2-ETHANOL
|
57944-79-3
|
C10H13NO
|
|
bis(2-hydroxy-3-decyloxypropyl)dimethylammonium chloride
|
57945-70-7
|
C28H60ClNO4
|
|
Methanesulfonamide, N-(3-cyanophenyl)-1,1,1-trifluoro-
|
57946-16-4
|
C8H5F3N2O2S
|
|
1-(3-AMINO-PHENYL)-2-BROMO-ETHANONE
|
57946-55-1
|
C8H8BrNO
|
|
4-Chloro-2-fluoroaniline
|
57946-56-2
|
C6H5ClFN
|
|
2-[(4-aminophenyl)amino]acetamide
|
57946-58-4
|
C8H11N3O
|
|
2-(2,2,2-TRIFLUOROETHOXY)ANILINE
|
57946-60-8
|
C8H8F3NO
|
|
4-(2,2,2-TRIFLUOROETHOXY)ANILINE
|
57946-61-9
|
C8H8F3NO
|
|
4-Amino-3-bromobenzotrifluoride
|
57946-63-1
|
C7H5BrF3N
|
|
N-(5-amino-2-chlorophenyl)acetamide(SALTDATA: FREE)
|
57946-67-5
|
C8H9ClN2O
|
|
3-(Hexadecylthio)aniline
|
57946-69-7
|
C22H39NS
|
|
2-bromo-4-(methylsulfonyl)benzenamine
|
57946-90-4
|
C7H8BrNO2S
|
|
CHEMBRDG-BB 7119554
|
57947-00-9
|
C8H13N3O2S
|
|
2-amino-N,N-diethylbenzenesulfonamide
|
57947-01-0
|
C10H16N2O2S
|
|
BIS(B-ALLYLOXYETHYL)ETHER
|
57947-82-7
|
C10H18O3
|